Barclays PLC Cutera Inc Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Cutera Inc stock. As of the latest transaction made, Barclays PLC holds 53 shares of CUTR stock, worth $6. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 53 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$0.66 - $1.67 $7,647 - $19,350	-11,587 Reduced 99.54%	53 $0
Q2 2024 Aug 14, 2024	SELL	$1.38 - $2.86 $1,733 - $3,592	-1,256 Reduced 9.74%	11,640 $17,000
Q1 2024 May 15, 2024	SELL	$1.39 - $4.79 $20,451 - $70,475	-14,713 Reduced 53.29%	12,896 $19,000
Q4 2023 Feb 15, 2024	BUY	$1.68 - $5.33 $7,153 - $22,695	4,258 Added 18.23%	27,609 $98,000
Q3 2023 Nov 07, 2023	SELL	$6.02 - $20.05 $578,221 - $1.93 Million	-96,050 Reduced 80.44%	23,351 $140,000
Q2 2023 Aug 03, 2023	BUY	$14.14 - $27.07 $588,026 - $1.13 Million	41,586 Added 53.44%	119,401 $1.81 Million
Q1 2023 May 04, 2023	BUY	$23.52 - $42.73 $636,898 - $1.16 Million	27,079 Added 53.37%	77,815 $1.84 Million
Q4 2022 Feb 13, 2023	BUY	$39.63 - $51.65 $298,532 - $389,079	7,533 Added 17.44%	50,736 $2.24 Million
Q3 2022 Nov 03, 2022	SELL	$37.04 - $54.04 $321,729 - $469,391	-8,686 Reduced 16.74%	43,203 $1.97 Million
Q2 2022 Aug 12, 2022	SELL	$36.55 - $72.31 $4,861 - $9,617	-133 Reduced 0.26%	51,889 $1.95 Million
Q1 2022 May 16, 2022	SELL	$32.12 - $69.0 $445,408 - $956,823	-13,867 Reduced 21.05%	52,022 $3.59 Million
Q4 2021 Feb 14, 2022	BUY	$33.71 - $46.72 $301,805 - $418,284	8,953 Added 15.72%	65,889 $2.72 Million
Q3 2021 Nov 09, 2021	BUY	$46.02 - $54.04 $511,420 - $600,546	11,113 Added 24.25%	56,936 $2.65 Million
Q2 2021 Aug 13, 2021	SELL	$27.5 - $49.11 $690,745 - $1.23 Million	-25,118 Reduced 35.41%	45,823 $2.25 Million
Q1 2021 May 13, 2021	BUY	$22.61 - $37.46 $1.16 Million - $1.93 Million	51,513 Added 265.15%	70,941 $2.13 Million
Q4 2020 Feb 11, 2021	SELL	$18.3 - $25.42 $33,013 - $45,857	-1,804 Reduced 8.5%	19,428 $469,000
Q3 2020 Nov 12, 2020	BUY	$11.42 - $20.56 $65,288 - $117,541	5,717 Added 36.85%	21,232 $403,000
Q2 2020 Aug 12, 2020	BUY	$10.7 - $15.87 $7,211 - $10,696	674 Added 4.54%	15,515 $189,000
Q1 2020 May 13, 2020	SELL	$9.19 - $37.11 $58,843 - $237,615	-6,403 Reduced 30.14%	14,841 $194,000
Q4 2019 Feb 10, 2020	BUY	$27.4 - $38.81 $205,774 - $291,463	7,510 Added 54.68%	21,244 $761,000
Q3 2019 Nov 14, 2019	SELL	$20.19 - $33.61 $51,100 - $85,066	-2,531 Reduced 15.56%	13,734 $401,000
Q2 2019 Aug 14, 2019	BUY	$16.3 - $20.78 $63,032 - $80,356	3,867 Added 31.19%	16,265 $338,000
Q1 2019 May 15, 2019	BUY	$12.35 - $19.14 $23,749 - $36,806	1,923 Added 18.36%	12,398 $220,000
Q4 2018 Feb 14, 2019	SELL	$14.36 - $30.7 $178,293 - $381,171	-12,416 Reduced 54.24%	10,475 $178,000
Q3 2018 Nov 14, 2018	BUY	$29.5 - $44.15 $419,195 - $627,371	14,210 Added 163.69%	22,891 $746,000
Q2 2018 Aug 14, 2018	SELL	$35.45 - $55.85 $236,416 - $372,463	-6,669 Reduced 43.45%	8,681 $349,000
Q1 2018 May 15, 2018	BUY	$44.25 - $54.6 $564,939 - $697,078	12,767 Added 494.27%	15,350 $772,000
Q4 2017 Feb 14, 2018	BUY	$37.35 - $48.5 $81,572 - $105,924	2,184 Added 547.37%	2,583 $117,000
Q3 2017 Nov 14, 2017	BUY	$25.65 - $41.35 $10,234 - $16,498	399	399 $17,000

Others Institutions Holding CUTR

# of Institutions

Shares Held

6.8M

Call Options Held

8.7K

Put Options Held

3.9K

Pura Vida Investments, LLC New York, NY

1.14M
Shares

$136,921
1.37% of portfolio
Voce Capital Management LLC San Francisco, CA

832K
Shares

$99,795
26.32% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

753K
Shares

$90,371
0.0% of portfolio
Hawk Ridge Capital Management LP Los Angeles, CA

445K
Shares

$53,389
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

404K
Shares

$48,464
0.0% of portfolio

View Full List

About CUTERA INC

Ticker CUTR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,575,400
Market Cap $2.35M
Description
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio...

More about CUTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account